Because SOX2 seems to be an important regulator of cancer stem cell function and of tumor-initiating potential in sporadic cSCCs, we surmised that SOX2 expression in EB-cSCCs can contribute to its aggressive phenotype. The gene discussed is SOX2; the disease is neoplasm.